News and Trends 12 Jul 2022
First patient receives new immunotherapy drug for HIV in clinical trial
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus (HIV) infection, has been given to the first patient in a clinical trial. Immunocare Holdings…